1,000 GIST patients join global effort to unlock tumor secrets
NCT ID NCT07273045
First seen Dec 16, 2025 · Last updated May 01, 2026 · Updated 17 times
Summary
This study is a registry that collects medical information and biological samples from 1,000 people diagnosed with gastrointestinal stromal tumors (GIST), a rare digestive tract cancer. It does not test any new treatments or require extra visits—participants continue their normal care. The goal is to better understand how GIST behaves, especially rare forms, and to identify factors that affect outcomes, helping design future studies and treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST - GASTROINTESTINAL STROMAL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Essem
Essen, North Rhine-Westphalia, 45147, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.